Improving healthcare quality and costs for older patients in Medicare programs
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
This study looks at how changing the way Medicare groups handle financial risks can help older patients get better care and save money, by seeing how these changes affect the quality and efficiency of healthcare services they receive.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11243575 on NIH RePORTER |
What this research studies
This research investigates how shifting financial risks in Medicare Accountable Care Organizations (ACOs) can enhance the quality of care and reduce costs for older patients. By analyzing the impact of requiring ACOs to take on downside risk, the study aims to understand how this change influences healthcare delivery and efficiency. The approach involves evaluating existing ACOs and their performance metrics to identify best practices and potential pitfalls in this transition. The goal is to ensure that older patients receive better coordinated and higher-quality healthcare services.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults who are currently receiving care through Medicare and are part of an ACO.
Not a fit: Patients who are not enrolled in Medicare or those receiving care outside of ACOs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare quality and reduced costs for older patients enrolled in Medicare.
How similar studies have performed: Previous evaluations of Medicare ACO initiatives have shown improvements in care quality, suggesting that this approach has potential based on past successes.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Hollenbeck, Brent K. — University of Michigan at Ann Arbor
- Study coordinator: Hollenbeck, Brent K.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.